🔍 RecallPedia

Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13

Class I - Dangerous
💊 Drugs Recalled: April 9, 2024 Second Tokushima Factory, Otsuka Pharmaceutical Co. Prescription Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Lot # AMS00223A, Exp 07/31/2025
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Reason for Recall:
Cross Contamination with Other Products
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
ongoing

Product Information

Full Description:

Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13

Product Codes/Lot Numbers:

Lot # AMS00223A, Exp 07/31/2025

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-0468-2024

Related Recalls